Cho S, Dadson K, Sung HK, Ayansola O, Mirzaesmaeili A, Noskovicova N, Zhao Y, Cheung K, Radisic M, Hinz B, Sater AAA, Hsu HH, Lopaschuk GD & Sweeney G. Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF). Biomedicine and Pharmacotherapeutics (2024) 171:116119
Sung HK, Tang J, Jahng JSW, Song E, Chan C, Peterson J, Abdul-Sater AA, & Sweeney G. Ischemia-induced cardiac dysfunction is exacerbated in adiponectin-knockout mice due to impaired autophagy flux. Clinical and Translational Science (2024) 17(3):e13758. doi: 10.1111/cts.13758.
Tang J, Tam E, Song E, Xu A, & Sweeney G. Crosstalk between myocardial autophagy and sterile inflammation in the development of heart failure. Autophagy Reports (2024) 3(1) 2320605
Nguyen K, Cho S, Tang J, Sung HK, Ying F, Pantopoulos K & Sweeney G. Salubrinal promotes phospho-eif2a-dependent activation of UPR leading to autophagy-mediated alleviation of iron overload-induced insulin resistance. Molecular Metabolism (2024) 83:101921
Lone AH, Tang J, Pignalosa A, Hsu HH, Abdul-Sater AA & Sweeney G. A novel blood-based bioassay to monitor adiponectin signaling. International Immunopharmacology (2024) 132: 111890
Tam E, Nguyen K, Sung HK, & Sweeney G. MitoNEET preserves muscle insulin sensitivity during iron overload by regulating mitochondrial iron, reactive oxygen species and fission. FEBS Journal (2024) doi: 10.1111/febs.17214
Tang J, Yoon N, Dadson K, Sung HK, Dang TQ, Lei Y, Chung WY, Wu J, Li RK, Jonkman J, Peterson JD & Sweeney G. Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heart. Autophagy Reports (2024) 3(1): 2330327
Huang Z, Sung HK, Yan X, He S, Jin L, Wang Q, Wu X, Sweeney G, & Xu A. A sustained release form of adiponectin-derived peptide ALY688 protects against the development of non-alcoholic steatohepatitis. Clinical & Translational Science (2024) 17(6):e13760.
Tang J, Lei Y, Pignalosa A, Hsu HH, Abdul-Sater AA & Sweeney G. Screening for blood-borne biomarkers of adiponectin action using the receptor agonist ALY688. iScience (2024) 27(10):110994
Gandhi S, Sweeney G & Perry CGR. Recent advances in developing adiponectin therapies for Duchenne muscular dystrophy. Biomedicines (2024) 12(7):1407
Bellissimo CA, Gandhi S, Castellani LN, Murugathasan M, Delfinis LJ, Thuhan A, Garibotti MC, Seo Y, Rebalka IA, Hsu HH, Sweeney G, Hawke TJ, Abdul-Sater AA & Perry CGR.
The slow-release adiponectin analogue ALY688-SR modifies early-stage disease
development in the D2.mdx mouse model of Duchenne muscular dystrophy
American Journal of Physiology (Cell) (2024) 326(4):C1011-C1026
Tam E, Song E, Noskovicova N, Hinz B, Xu A & Sweeney G
Autophagy deficiency exacerbated hypoxia-reoxygenation induced inflammation and cell
death via a mitochondrial DNA/STING/IRF3 pathway
Life Sciences (2024) 358:123173